Neon Therapeutics Inc (NTGN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

40 ERIE STREET CAMBRIDGE, MA 02139

Neon Therapeutics, Inc. operates as a biotechnology company. The Company offers a neoantigen platform to develop neoantigen-targeted therapies for the treatment of cancer by directing the immune system. Neon Therapeutics offers its services in the United States.

Data as of 2019-12-02 13:40:49 -0500
Market Cap32.306 Million Shares Outstanding28.339 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-3.07
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low7.51 / 1.09 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from NTGN instead.

View recent insider trading info

Funds Holding NTGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NTGN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHERWIN STEPHEN A

  • Director
No longer subject to file 2020-05-06 0

TEPPER ROBERT I

  • Director
  • 10% Owner
No longer subject to file 2020-05-06 0

LANDER ERIC S

  • Director
No longer subject to file 2020-05-06 0

PFEFFER CARY

  • Director
No longer subject to file 2020-05-06 0

BAZEMORE ROBERT B

  • Director
No longer subject to file 2020-05-06 0

AL-WAKEEL YASIR B. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2020-05-06 0

KAMEN ROBERT

  • Director
No longer subject to file 2020-05-06 0

O'DOWD HUGH PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2020-05-06 0

GAYNOR RICHARD PRESIDENT OF R&D

  • Officer
No longer subject to file 2020-05-06 0

ZAUSNER MERYL

  • Director
No longer subject to file 2020-05-06 0

SIEGEL JOLIE VP, GENERAL COUNSEL

  • Officer
No longer subject to file 2020-05-06 0

ACCESS INDUSTRIES HOLDINGS LLC

CLAL BIOTECHNOLOGY INDUSTRIES LTD.

ACCESS INDUSTRIES, LLC

ACCESS INDUSTRIES MANAGEMENT, LLC

BLAVATNIK LEN

  • 10% Owner
  • SEE REMARKSAFFILIATE OF 10% OWNERAFFILIATE OF 10% OWNERAFFILIATE OF 10% OWNER
No longer subject to file 2020-03-23 0

ANG ROBERT CHIEF BUSINESS OFFICER

  • Officer
279,525 2019-02-27 0

BAZEMORE ROBERT B

BAZEMORE ROBERT B

  • Director
0 2018-11-07 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

STARR KEVIN P

LEVIN MARK J

  • 10% Owner
9,741,636 2018-06-29 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
No longer subject to file 2018-06-29 0

ADAMS JULIAN

  • Director
0 2018-06-26 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
0 2018-06-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments